Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma

Torben Plesner; Hendrik-Tobias Arkenau; Peter Gimsing; Jakub Krejcik; Charlotte Lemech; Monique C. Minnema; Ulrik Lassen; Jacob P. Laubach; Antonio Palumbo; Steen Lisby; Linda Basse; Jianping Wang; A. Kate Sasser; Mary E. Guckert; Carla de Boer; Nushmia Z. Khokhar; Howard Yeh; Pamela L. Clemens; Tahamtan Ahmadi; Henk M. Lokhorst; Paul G. Richardson

doi:10.1182/blood-2016-07-726729

Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma

Torben Plesner
, Hendrik-Tobias Arkenau
, Peter Gimsing
, Jakub Krejcik
, Charlotte Lemech
, Monique C. Minnema
, Ulrik Lassen
, Jacob P. Laubach
, Antonio Palumbo
, Steen Lisby
, Linda Basse
, Jianping Wang
, A. Kate Sasser
, Mary E. Guckert
, Carla de Boer
, Nushmia Z. Khokhar
, Howard Yeh
, Pamela L. Clemens
, Tahamtan Ahmadi
, Henk M. Lokhorst

Paul G. Richardson

Affiliatie VU

Research output: Contribution to journal › Article › Academic › peer-review

10 Downloads (Pure)

Original language	English
Pages (from-to)	1821-1828
Journal	Blood
Volume	128
Issue number	14
DOIs	https://doi.org/10.1182/blood-2016-07-726729
Publication status	Published - 6 Oct 2016

Access to Document

10.1182/blood-2016-07-726729

Phase-12-study-of-daratumumab-lenalidomide-and-dexamethasone-for-relapsed-multiple-myeloma.pdfFinal published version, 699 KBLicence: Taverne

Cite this

Plesner, T., Arkenau, H.-T., Gimsing, P., Krejcik, J., Lemech, C., Minnema, M. C., Lassen, U., Laubach, J. P., Palumbo, A., Lisby, S., Basse, L., Wang, J., Sasser, A. K., Guckert, M. E., de Boer, C., Khokhar, N. Z., Yeh, H., Clemens, P. L., Ahmadi, T., ... Richardson, P. G. (2016). Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma. Blood, 128(14), 1821-1828. https://doi.org/10.1182/blood-2016-07-726729

@article{39fc24b4eae6497a88099257901fc99d,

title = "Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma",

author = "Torben Plesner and Hendrik-Tobias Arkenau and Peter Gimsing and Jakub Krejcik and Charlotte Lemech and Minnema, \{Monique C.\} and Ulrik Lassen and Laubach, \{Jacob P.\} and Antonio Palumbo and Steen Lisby and Linda Basse and Jianping Wang and Sasser, \{A. Kate\} and Guckert, \{Mary E.\} and \{de Boer\}, Carla and Khokhar, \{Nushmia Z.\} and Howard Yeh and Clemens, \{Pamela L.\} and Tahamtan Ahmadi and Lokhorst, \{Henk M.\} and Richardson, \{Paul G.\}",

year = "2016",

month = oct,

day = "6",

doi = "10.1182/blood-2016-07-726729",

language = "English",

volume = "128",

pages = "1821--1828",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "14",

}

Plesner, T, Arkenau, H-T, Gimsing, P, Krejcik, J, Lemech, C, Minnema, MC, Lassen, U, Laubach, JP, Palumbo, A, Lisby, S, Basse, L, Wang, J, Sasser, AK, Guckert, ME, de Boer, C, Khokhar, NZ, Yeh, H, Clemens, PL, Ahmadi, T, Lokhorst, HM & Richardson, PG 2016, 'Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma', Blood, vol. 128, no. 14, pp. 1821-1828. https://doi.org/10.1182/blood-2016-07-726729

TY - JOUR

T1 - Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma

AU - Plesner, Torben

AU - Arkenau, Hendrik-Tobias

AU - Gimsing, Peter

AU - Krejcik, Jakub

AU - Lemech, Charlotte

AU - Minnema, Monique C.

AU - Lassen, Ulrik

AU - Laubach, Jacob P.

AU - Palumbo, Antonio

AU - Lisby, Steen

AU - Basse, Linda

AU - Wang, Jianping

AU - Sasser, A. Kate

AU - Guckert, Mary E.

AU - de Boer, Carla

AU - Khokhar, Nushmia Z.

AU - Yeh, Howard

AU - Clemens, Pamela L.

AU - Ahmadi, Tahamtan

AU - Lokhorst, Henk M.

AU - Richardson, Paul G.

PY - 2016/10/6

Y1 - 2016/10/6

U2 - 10.1182/blood-2016-07-726729

DO - 10.1182/blood-2016-07-726729

M3 - Article

C2 - 27531679

SN - 0006-4971

VL - 128

SP - 1821

EP - 1828

JO - Blood

JF - Blood

IS - 14

ER -